UK National Smoking Cessation Conference - UKNSCC
2010 UK National Smoking Cessation Conference - Glasgow more...
 

Smoking cessation medications: compliance, adherence and concordance

< BACK

Listen to the speech online audio

 

Author and presenter:
Rob Horne
Professor of Behavioural Medicine, Head of Department of Practice and Policy and Director, Centre for Behavioural Medicine, The School of Pharmacy, University of London, UK

No abstract available at time of going to print.

About the presenter
Rob Horne is Professor of Behavioural Medicine at the School of Pharmacy, University of London and an internationally recognised expert in self-management of chronic illness and adherence to medications. He is a pharmacist with a PhD in Health Psychology.
His career combines over ten years experience of clinical pharmacy practice and NHS management with a fifteen year programme of research into the psychology of medicines usage. This research has generated over 90 peer-reviewed publications and grants totalling over £4.2 million. Its relevance is evidenced by Rob Horne’s contributions to national and international reports and guidelines on adherence, by consultancy work for national charities, the NHS and commercial health care organisations.

In 2006, Professor Horne joined the School of Pharmacy where he founded and continues to lead the Centre for Behavioural Medicine within the Department of Practice and Policy and in June 2008 became Head of Department. He is Visiting Professor at the School of Medicine, King’s College London and in the Department of Psychology at University College London and a Visiting Fellow at the Institute of Psychiatry, King’s College London. In 2006 he led a review of the field of compliance, adherence and concordance in medicine taking by the UK NIHR and is a member of the NICE Concordance Committee. Rob is also currently engaged in the Department of Health’s Communications Strategy in Chronic Obstructive Pulmonary Disease (COPD) (part of their wider Strategy for COPD), which aims to impact on its earlier identification by developing communications to promote greater public awareness and understanding of the disease.

 

 
related pages